Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.

Welzel T, Schöbi N, André MC, Bailey DGN, Blanchard-Rohner G, Buettcher M, Grazioli S, Koehler H, Perez MH, Trück J, Vanoni F, Zimmermann P, Atkinson A, Sanchez C, Whittaker E, Faust SN, Bielicki JA, Schlapbach LJ, Swissped Recovery Trial

Open source

DOI: 10.3389/fped.2022.905046
Published: 2022
Container: Frontiers in pediatrics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fped.2022.905046,
  title = {Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.},
  author = {Welzel T and Schöbi N and André MC and Bailey DGN and Blanchard-Rohner G and Buettcher M and Grazioli S and Koehler H and Perez MH and Trück J and Vanoni F and Zimmermann P and Atkinson A and Sanchez C and Whittaker E and Faust SN and Bielicki JA and Schlapbach LJ and Swissped Recovery Trial},
  year = {2022},
  journal = {Frontiers in pediatrics},
  doi = {10.3389/fped.2022.905046},
  url = {https://doi.org/10.3389/fped.2022.905046}
}

RIS

TY  - JOUR
TI  - Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.
AU  - Welzel T
AU  - Schöbi N
AU  - André MC
AU  - Bailey DGN
AU  - Blanchard-Rohner G
AU  - Buettcher M
AU  - Grazioli S
AU  - Koehler H
AU  - Perez MH
AU  - Trück J
AU  - Vanoni F
AU  - Zimmermann P
AU  - Atkinson A
AU  - Sanchez C
AU  - Whittaker E
AU  - Faust SN
AU  - Bielicki JA
AU  - Schlapbach LJ
AU  - Swissped Recovery Trial
PY  - 2022
JO  - Frontiers in pediatrics
DO  - 10.3389/fped.2022.905046
UR  - https://doi.org/10.3389/fped.2022.905046
ER  -

APA

T, W., N, S., MC, A., DGN, B., G, B., M, B., S, G., H, K., MH, P., J, T., F, V., P, Z., A, A., C, S., E, W., SN, F., JA, B., LJ, S., & Trial, S. R. (2022). Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.. Frontiers in pediatrics. https://doi.org/10.3389/fped.2022.905046

Source records

pubmed · retrieved 2026-09-26T12:50:28.483Z